Schizophrenia Clinical Trial
Official title:
"MADOCS: Manual Dexterity and Oculomotor Control as Vulnerability Markers in Schizophrenia"
The investigators recently showed that visuomotor integration was significantly altered in schizophrenic patients during: (i) a grip force task (Teremetz et al., 2014), and (ii) a saccadic paradigm (oculomotor task)(Amado et al., 2008). Given this findings, the investigators propose a combined study of oculomotor and grip force control to better characterize the sensorimotor integration deficit. This approach may allow for identification of behavioural biomarkers of vulnerability to develop schizophrenia.
1 - Scientific background and rational Use of sensory cues is essential for execution and
correction of voluntary movements. The motor areas and their regulation is of special
interest in patients with schizophrenia as there is clear evidence of motor abnormalities
independent of the effects of antipsychotic medication, even before the onset of the
disorder. Sensorimotor abnormalities have been proposed as a valid endophenotype in
schizophrenia. Our global objective is to study and provide vulnerability markers for
schizophrenia.
1. Control of manual dexterity will be assessed by a force sensor (Power Grip Manipulandum,
PGM)
2. Oculomotor movements during behavioral task will be recorded using a video-oculography
device
3. The involvement of cortical inhibition in this volitional inhibition task will be
studied by neuronavigation guided TMS coupled to EMG recording
2 - Description of the project methodology There is strong evidence for schizophrenia being a
neuro-developmental disorder (Rapoport et al., 2005). It has been shown, for many years, that
patients with schizophrenia exhibit abnormal patterns of sensorimotor integration (Manschreck
et al., 1982), which is the capacity to integrate different sensory stimuli into appropriate
motor actions. It is clinically relevant, in terms of early diagnosis and prevention, whether
deficient sensorimotor integration is present in the prodromal phase of schizophrenia, and
whether this constitutes a vulnerability marker for the disease.
Our global objective is to study the interactions and related substratum of oculomotor
movements during force control task.
The secondary objectives:
(i) To show that increased motor noise is indeed present in schizophrenia. (ii) To show by
TMS that cortical excitability in the primary motor cortex (M1) is task-modulated and
decreased in schizophrenia.
(iii) Assess the role of deficient cortical inhibition in these behavioral deficits To this
end, three different groups of subjects will be studied: schizophrenic patients, non-affected
siblings, ultra high risk patients, non-treated schizophrenic patients and healthy control
subjects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |